Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New levobupivacaine clinical data presented at European congress

Sep. 23, 1997

Acetylcholinesterase inhibitors under development at Astra

Sep. 23, 1997

New compounds from Knoll for CNS disorders

Sep. 23, 1997

Pfizer describes agents for dopamine system disorders

Sep. 23, 1997

Pramipexole monotherapy treats parkinsonian symptoms for up to two years

Sep. 22, 1997

Eisai presents novel potential antipsychotic agent

Sep. 22, 1997

Highly selective 5-HT1D agonists described by MS&D

Sep. 22, 1997

Taisho/Nihon Nohyaku evaluate thiazole derivatives as antipsychotics

Sep. 22, 1997

Carbachol analogue selective for m1 receptors in vivo

Sep. 22, 1997

Tachykinin antagonists prepared at Janssen

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...